If you are a journalist, our media relations experts can:
On Global Edmonton’s Health Matters segment, GlycoNet CEO Elizabeth Nanak and 48Hour Discovery CEO Ratmir Derda shared how glycomics research is driving new health solutions & speeding up drug discovery (March 23, 2022).
“We will, in the next several months, know how well our vaccine did against Omicron,” the company’s medical officer, Dr. Brian Ward, told CBC News, citing ongoing company trials. (CBC News, February 2022)
Dr. Matthew Macauley talked to CBC Radio Active about a promising promising development in the battle against the disease (CBC Radio Active with Adrienne Pan, December 2019)
Dr. Don Sheppard, co-director and founder of MI4 spoke to CTV Montreal about the initiative and its goals to control and evolve around Superbugs. (CTV Montreal, May 2019)
High school teachers were on the other side of the classroom with the chance to play with the research on carbohydrates. (Edmonton Journal, December 2018)
Dr. Robert Britton has embarked on an ambitious project to develop carbohydrate mimics to assist cancer therapies. (Medical Xpress, May 2018)
Researchers found molecules to prevent ice crystals from forming, thus protecting cells from damage during cryopreservation.
Biochemist and 48Hour Discovery founder Ratmir Derda hopes the Edmonton-based company will become “the next molecular Google.” (Edmonton Journal, December 2017)
Canadian researchers have discovered the defence mechanism of the often deadly fungus and are developing ways to fight it by using its own defences against it. (Radio Canada International, November 2015)
Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.